690 related articles for article (PubMed ID: 24014598)
1. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review.
Gierisch JM; Coeytaux RR; Urrutia RP; Havrilesky LJ; Moorman PG; Lowery WJ; Dinan M; McBroom AJ; Hasselblad V; Sanders GD; Myers ER
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1931-43. PubMed ID: 24014598
[TBL] [Abstract][Full Text] [Related]
2. Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study.
Urban M; Banks E; Egger S; Canfell K; O'Connell D; Beral V; Sitas F
PLoS Med; 2012; 9(3):e1001182. PubMed ID: 22412354
[TBL] [Abstract][Full Text] [Related]
3. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
Petitti DB; Porterfield D
Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
[TBL] [Abstract][Full Text] [Related]
4. [The risk of breast cervical, endometrial and ovarian cancer in oral contraceptive users].
Veljković M; Veljković S
Med Pregl; 2010; 63(9-10):657-61. PubMed ID: 21446095
[TBL] [Abstract][Full Text] [Related]
5. [Use of oral contraceptives and risk of cancer, a cohort study].
Kumle M; Alsaker E; Lund E
Tidsskr Nor Laegeforen; 2003 Jun; 123(12):1653-6. PubMed ID: 12821980
[TBL] [Abstract][Full Text] [Related]
6. Cancers in Australia in 2010 attributable to and prevented by the use of combined oral contraceptives.
Jordan SJ; Wilson LF; Nagle CM; Green AC; Olsen CM; Bain CJ; Pandeya N; Whiteman DC; Webb PM
Aust N Z J Public Health; 2015 Oct; 39(5):441-5. PubMed ID: 26437729
[TBL] [Abstract][Full Text] [Related]
7. Modification of the Associations Between Duration of Oral Contraceptive Use and Ovarian, Endometrial, Breast, and Colorectal Cancers.
Michels KA; Pfeiffer RM; Brinton LA; Trabert B
JAMA Oncol; 2018 Apr; 4(4):516-521. PubMed ID: 29346467
[TBL] [Abstract][Full Text] [Related]
8. Oral contraceptives and gynecologic cancer: an update for the 1990s.
Kaunitz AM
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1171-6. PubMed ID: 1415442
[TBL] [Abstract][Full Text] [Related]
9. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study.
Iversen L; Sivasubramaniam S; Lee AJ; Fielding S; Hannaford PC
Am J Obstet Gynecol; 2017 Jun; 216(6):580.e1-580.e9. PubMed ID: 28188769
[TBL] [Abstract][Full Text] [Related]
10. Oral contraceptive use for the primary prevention of ovarian cancer.
Havrilesky LJ; Gierisch JM; Moorman PG; Coeytaux RR; Urrutia RP; Lowery WJ; Dinan M; McBroom AJ; Wing L; Musty MD; Lallinger KR; Hasselblad V; Sanders GD; Myers ER
Evid Rep Technol Assess (Full Rep); 2013 Jun; (212):1-514. PubMed ID: 24423062
[TBL] [Abstract][Full Text] [Related]
11. Oral contraceptive use and cancer: final report from the Oxford-Family Planning Association contraceptive study.
Vessey M; Yeates D
Contraception; 2013 Dec; 88(6):678-83. PubMed ID: 24090961
[TBL] [Abstract][Full Text] [Related]
12. Oral contraceptives and reproductive system cancer.
Deligeoroglou E; Michailidis E; Creatsas G
Ann N Y Acad Sci; 2003 Nov; 997():199-208. PubMed ID: 14644827
[TBL] [Abstract][Full Text] [Related]
13. Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use.
dos Santos Silva I; Swerdlow AJ
Br J Cancer; 1995 Aug; 72(2):485-92. PubMed ID: 7640237
[TBL] [Abstract][Full Text] [Related]
14. Oral contraceptive use and risk of cancer--response.
Gierisch JM; Myers ER
Cancer Epidemiol Biomarkers Prev; 2014 Apr; 23(4):677-8. PubMed ID: 24636973
[No Abstract] [Full Text] [Related]
15. Net effect of oral contraceptive use on the risk of cancer in women in the United States.
Schlesselman JJ
Obstet Gynecol; 1995 May; 85(5 Pt 1):793-801. PubMed ID: 7724116
[TBL] [Abstract][Full Text] [Related]
16. [Use of oral contraceptives and increased risk of cervical cancer].
Schmeink CE; Lenselink CH; Bekkers RL
Ned Tijdschr Geneeskd; 2008 Aug; 152(31):1717-8. PubMed ID: 18727601
[TBL] [Abstract][Full Text] [Related]
17. Oral contraceptive use and risk of cancer--letter.
Weiss NS
Cancer Epidemiol Biomarkers Prev; 2014 Apr; 23(4):676. PubMed ID: 24636972
[No Abstract] [Full Text] [Related]
18. Oral contraceptives and cancers of the breast and of the female genital tract. Interim results from a case-control study.
La Vecchia C; Decarli A; Fasoli M; Franceschi S; Gentile A; Negri E; Parazzini F; Tognoni G
Br J Cancer; 1986 Aug; 54(2):311-7. PubMed ID: 3741766
[TBL] [Abstract][Full Text] [Related]
19. Oral contraceptives and cancer.
Edgren RA
Int J Fertil; 1991; 36 Suppl 3():37-50. PubMed ID: 1687403
[TBL] [Abstract][Full Text] [Related]
20. Time-Dependent Effects of Oral Contraceptive Use on Breast, Ovarian, and Endometrial Cancers.
Karlsson T; Johansson T; Höglund J; Ek WE; Johansson Å
Cancer Res; 2021 Feb; 81(4):1153-1162. PubMed ID: 33334812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
